Cwm, LLC Annexon, Inc. Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Cwm, LLC holds 23,488 shares of ANNX stock, worth $67,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,488

Previous 17,734 32.45%

Holding current value

$67,175

Previous $43,000 67.44%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$2.05 - $3.37 $11,795 - $19,390	5,754 Added 32.45%	23,488 $72,000
Q2 2025 Jul 25, 2025	BUY	$1.38 - $2.73 $16,651 - $32,940	12,066 Added 212.88%	17,734 $43,000
Q1 2025 May 01, 2025	BUY	$1.93 - $5.5 $7,847 - $22,363	4,066 Added 253.81%	5,668 $11,000
Q4 2024 Feb 04, 2025	SELL	$4.44 - $7.63 $16,650 - $28,612	-3,750 Reduced 70.07%	1,602 $8,000
Q3 2024 Oct 08, 2024	BUY	$4.49 - $7.2 $12,769 - $20,476	2,844 Added 113.4%	5,352 $32,000

Q2 2024 Jul 09, 2024	BUY	$4.33 - $6.79 $10,786 - $16,913	2,491 Added 14652.94%	2,508 $12,000
Q1 2024 Apr 05, 2024	BUY	$4.03 - $7.81 $68 - $132	17 New	17 $0

Others Institutions Holding ANNX

# of Institutions

151

Shares Held

101M

Call Options Held

88.6K

Put Options Held

32.5K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $136M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account